22nd International Symposium on Infections in the Critically Ill Patient
Start:
Wed, 8 Feb 2017, 08:45
End:
Fri, 10 Feb 2017, 01:00
Website:
Venue:
KEYNOTE SPEAKERS
Prof. Antonio Artigas, MD, PhD
ICU Management & Practice Editorial Board Member
******@***cspt.es
- Dept. of Intensive Care Medicine Hospital de Sabadell - CIBER de Enfermedades Respiratorias Corporació Sanitaria I Universitària Parc Taulí Sabadell, Spain
Prof. Michael Niederman, MD, MACP, FCCP, FCCM, FERS
******@***med.cornell.edu
- Clinical Director, Pulmonary and Critical Care - New York Presbyterian-Weill Cornell Medical Center (2015-)
- Professor of Clinical Medicine - Weill Cornell Medical College (2015-)
Prof Jean-Louis Vincent, MD, PhD
Editor-in-Chief, ICU Management & Practice
******@***icu-management.org
- Professor - Department of Intensive Care Erasme Hospital Université libre de Bruxelles
- Brussels, Belgium
Exhibit
Symposia
Workshops
Organiser
Sponsor
Posters
ORGANIZED BY
Antonio Artigas, MD Jean Carlet, MD Paulo Mergulhão, MD Michael Niederman, MD José Arthur Paiva, MD Antoni Torres, MD |
ENDORSED BY
Prior to 31/12/2016 | After 31/12/2016 | |
*MEMBERS | 250€ | 350€ |
NON MEMBERS | 350€ | 450€ |
One day offer | ||
Prior to 31/12/2016 | After 31/12/2016 | |
*MEMBERS | 85€ | 150€ |
NON MEMBERS | 100€ | 180€ |
The following registration fees include access to the
Scientific Sessions and the Commercial Exhibition, Conference documents,
Certificate of Attendance and Coffee Breaks
* Members of:
- Ciberes
- ESA
- GSA
- ICHS
- ISF
- Separ
- SPDIMC
- SPD
- SRLF
** A letter signed by the institution responsible is required to get this fee..
To Register, Please fill the form (type or block capital letters) and mail it or fax it directly to the Symposium Technical Secretariat:
Diagonal 662-664.
08034 Barcelona, Spain
Tel. + 34 93 252 04 00
Fax +34 93 206 57 91
[email protected]
PDF Registration Form
Wednesday, February 8th, 2017 | |
08:45 | Introduction |
A.Artigas, MD (Sabadell, Spain) | |
J.Carlet, MD (Paris, France) | |
P.Mergulhão, MD (Porto, Portugal) | |
M.Niederman, MD (New York, USA) | |
JA.Paiva, MD (Porto, Portugal) | |
I. SEPSIS | |
09:00 | Surviving Sepsis Campaign Guidelines 2016: What changed? -M.Levy, MD (Rhode Island, USA) |
09:20 | Outlook for Sepsis: Do We Have a Roadmap- T.Calandra, MD (Lausanne, Switzerland) |
09:40 | Post-ICU Sepsis: The OUTCOME Study- J.Gonçalves Pereira, MD (Lisboa, Portugal) |
10:00 | Big Data For Better Sepsis Management -H.Gerlach, MD (Berlin, Germany) |
10:20 | Discussion |
10:30 | Break (Exhibition Area). Poster Discussion |
II. THE END OF EGDT? | |
11:00 | Lactate Clearance: How Much Is a Marker Response?- M.Levy, MD (Rhode Island, USA) |
11:20 | Protocol vs Individualized Treatment- M.Cecconi, MD (London, UK) |
11:40 | What Do I in my ICU? -C.Martin, MD (Marseille, France) |
12:00 | Therapeutical Goals For 2017 and Beyond- JL.Vincent, MD (Brussels, Belgium) |
12:20 | Discussion |
12:30 | Debate: New Sepsis Definitions: Real Progress? |
Moderator: I.Martin Loeches, MD (Dublin, Ireland) | |
Pro: JL.Vincent, MD (Brussels, Belgium) | |
Con: R.Ferrer, MD (Barcelona, España) | |
13:00 | Lunch |
Symposium | |
VASCULAR TONE OR VOLUME STATUS? | |
Moderators: JL.Teboul, MD (Paris, France) | |
C.Martin, MD (Marseille, France) | |
14:00 | Volume Status and Fluid Resuscitation: What is the solution? -M.Cecconi, MD (London, UK) |
14:20 | The SOSD Phases of Fluid Therapy- D.De Backer, MD (Brussels, Belgium) |
14:40 | Vassopressors in Sepsis: When to Start?- JL.Teboul, MD (Paris, France) |
15:00 | Discussion |
III. DYSFUNCTION OF MICROCIRCULATION IN SEPSIS | |
15:30 | Role Od Gut in Sepsis and MOF?- J. De Waele, MD (Gent, Belgium) |
15:50 | How to evaluate the Microcirculation?- C.Ince, MD (Amsterdam, The Netherlands) |
16:10 | How to Improve Microcirculation?- D.De Backer, MD (Brussels, Belgium) |
16:30 | Discussion |
16:40 | Break (Exhibition Area). Poster Discussion |
Symposium | |
SEPSIS ASSOCIATED COAGULOPATHY | |
Moderators: A. Artigas, MD (Sabadell, Spain) | |
M.Schultz, MD (Amsterdam, The Netherlands) | |
17:10 | Sepsis-Associated Coagulopathy: Still Common and |
Still Important- A. Artigas, MD (Sabadell, Spain) | |
17:30 | Organ Dysfunction and Coagulation in Sepsis- M.Levi, MD (Amsterdam, The Netherlands) |
17:50 | Thrombomodulin In Sepsis: The SCARLET Study- JL.Vincent, MD (Brussels, Belgium) |
18:10 | Discussion |
Thursday, February 9th, 2017 | |
IV. NEW INSIGHTS IN THE PATHOGENESIS OF PNEUMONIA IN INTUBATED AND MECHANICAL VENTILATED PATIENTS | |
09:00 | Changes in Microbiome During Mechanical Ventilation- LD Boss, MD (Amsterdam, Netherlands) |
09:20 | From Tracheobronchitis to VAP- S. Nseir, MD (Lille, France) |
09:40 | Selective Advantage of Multi-Drug Resistant Microbe During Prolonged Ventilation- I.Martin Loeches, MD (Dublin, Ireland) |
10:00 | Discussion |
10:10 | Break (Exhibition Area). Poster Discussion |
V. MANAGEMENT OF PULMONARY INFECTIONS | |
10:40 | Management of Severe Influenza Infections- MS.Niederman, MD (New York, USA) |
11:00 | Virus as a Cause of VAP- F.Froes, MD (Lisboa, Portugal) |
11:20 | Tracheostomy Practices: Are Risk Factors for VAP?- M.Antonelli, MD (Rome, Italy) |
11:40 | Ventilatory Support and VAP Prevention in Auster Seetings, Also Applicable in Your Unit? -M.Schultz, MD (Amsterdam, The Netherlands) |
12:00 | Novel Approaches to Treat Pulmonary Infections- T.Welte, MD (Hannover, Germany) |
12:20 | Discussion |
12:20 | Lunch |
Symposium | |
CONTROVERSIES AND ADVANCES IN THE MANAGEMENT OF VAP | |
Moderators: I.Martin Loeches, MD (Dublin, Ireland) | |
JM Pereira, MD (Porto, Portugal) | |
13:30 | Can Antiinflammatory Therapy Help Improve Outcome in VAP?- A.Torres, MD (Barcelona, Spain) |
13:50 | Are New Antibiotics Going To Help Us Manage VAP in the ICU?- MS.Niederman, MD (New York, USA) |
14:10 | Can Biomarkers Help With Antibiotic Stewardship?- J.Chastre, MD (Paris, France) |
14:30 | Discussion |
VI. POINT-OF-CARE APPROACH TO INFECTIONS IN THE ICU | |
14:40 | Early MIcrobiological Diagnostics on the ICU. Is it Possible?- E.Bouza, MD (Madrid, Spain) |
15:00 | Virus Diagnosis Is Important in the ICU?- J.Chastre, MD (Paris, France) |
15:20 | Biomarkers In AKI |
15:40 | Sepsis Biomarkers: An Overview- JL.Vincent, MD (Brussels, Belgium) |
16:00 | Discussion |
16:10 | Break (Exhibition area). Poster Discussion |
VII. FROM THE PHYSIOPATHOLOGY TO THE BEDSIDE: THE IMMUNE RESPONSE | |
16:40 | Sepsis: Ressistance vs Tolerance. Change of Paradigm- L.Moita, MD (Lisboa, Portugal) |
17:00 | Immunosupression in Sepsis: Is it important?- D.Payen, MD (Paris, France) |
17:20 | Semi-Selective Immune Modulation Using Hemoabsorption |
17:40 | Polimixin B Hemoperfusion: The EUPHRATES Study- M.Antonelli, MD (Rome, Italy) |
18:00 | Discussion |
Friday, February 10th, 2017 | |
VIII. NEW INSIGHTS OF ANTIBIOTIC THERAPY | |
09:00 | New Antibiotics for the Treatment of Severe Infections -T.Calandra, MD (Lausanne, Switzerland) |
09:20 | Can We Reduce Antibiotic Resistance?- J.Carlet, MD (Paris, France) |
09:40 | Combination of Betalactam: When and Why?- JM Pereira, MD (Porto, Portugal) |
10:00 | Antibiotic in Extracorporeal Techniques -J.Gonçalves Pereira, MD (Lisboa, Portugal) |
10:20 | Continuous or Prolonged Infussion of Antibiotics- J.De Waele, MD (Gent, Belgium) |
10:50 | Discussion |
11:00 | Break (Exhibition Area). Poster Discussion |
IX. WHAT IS NEW IN FUNGAL INFECTIONS | |
11:30 | Prophylaxis and Prevention Therapy for Fungal Infections- T.Calandra, MD (Lausanne, Switzerland) |
11:50 | D-Escalation Therapy in Patients With Invasive Candidiasis- J.Garnacho-Montero, MD (Sevilla, Spain) |
12:10 | How Could We Reduce Antifungal Use? The STAFE Study-S.Nseir, MD (Lille, France) |
12:30 | Fungemia: What Is New? -JA.Paiva, MD (Porto, Portugal) |
12:50 | Discussion |
13:00 | Closing Remarks |
Postgraduate Courses | |
NUTRITION THERAPY: State of the Art | |
ANTIBIOTIC THERAPY |
More events
Wed, 4 Dec 2024 - Fri, 6 Dec 2024